【上海生物医药并购私募基金成立 出资额46.6亿元】 公开资料显示,近日,上海生物医药并购私募基金合伙企业成立,出资额46.6亿元,经营范围包含:以私募基金从事股权投资、投资管理、资产管理等活动。股权数据显示,该合伙企业由成都交子中赢创新发展基金合伙企业、东富龙、君实生物等共同持股。

金融界
Mar 27, 2025
公开资料显示,近日,上海生物医药并购私募基金合伙企业成立,出资额46.6亿元,经营范围包含:以私募基金从事股权投资、投资管理、资产管理等活动。股权数据显示,该合伙企业由成都交子中赢创新发展基金合伙企业、东富龙君实生物等共同持股。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10